Trial Profile
Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2024
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary) ; Sodium nitrite
- Indications Pulmonary arterial hypertension
- Focus Biomarker; Diagnostic use
- 25 May 2014 New trial record